| Inducible T-cell costimulator mediates lymphocyte/macrophage interactions during liver repair NN Ramavath, LL Gadipudi, A Provera, LC Gigliotti, E Boggio, C Bozzola, ... Frontiers in Immunology 12, 786680, 2021 | 14 | 2021 |
| SerpinB3 as a pro-inflammatory mediator in the progression of experimental non-alcoholic fatty liver disease E Novo, A Cappon, G Villano, S Quarta, S Cannito, C Bocca, C Turato, ... Frontiers in immunology 13, 910526, 2022 | 13 | 2022 |
| Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis LL Gadipudi, NN Ramavath, A Provera, C Reutelingsperger, E Albano, ... Clinical Science 136 (9), 643-656, 2022 | 11 | 2022 |
| Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis A Provera, NN Ramavath, LL Gadipudi, CL Gigliotti, E Boggio, C Vecchio, ... Frontiers in Immunology 14, 1290391, 2023 | 3 | 2023 |
| Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis B Foglia, S Sutti, S Cannito, C Rosso, M Maggiora, A Casalino, C Bocca, ... Frontiers in Immunology 15, 1342404, 2024 | 2 | 2024 |
| Co-stimulatory signals mediated by ICOS/ICOS-L dyad influence the differentiation of liver NASH-associated macrophages (NAMs) NN Ramavath, LI Gadipudiaik, A Provera, LC Gigliotti, E Boggio, ... International Liver Congress, 2021 | 2 | 2021 |
| From MASLD to HCC: what’s in the middle? A Provera, C Vecchio, AN Sheferaw, I Stoppa, D Pantham, U Dianzani, ... Heliyon, 2024 | | 2024 |
| FRI-479-YI The role of OSM/OSMRβ axis in shaping the immunemicroenvironment favouring MASLD-related HCC immune evasion B Foglia, J Nurcis, A Provera, C Rosso, GP Caviglia, E Bugianesi, ... Journal of Hepatology 80, S421, 2024 | | 2024 |
| The OSM/OSMRβ signalling axis in the development of MASLD-related hepatocellular carcinoma J Nurcis, S Sutti, B Foglia, A Provera, C Vecchio, C Rosso, M Maggiora, ... Digestive and Liver Disease 56, S95, 2024 | | 2024 |
| SAT112 Ad Libitum Ketogenic Diet Reverts WD-pathological Effects In Liver, But Not In Skeletal Muscle In Mice A Antonioli, A Provera, S Reano, LL Gadipudi, S Tini, I Zaggia, T Raiteri, ... Journal of the Endocrine Society 7 (Supplement_1), bvad114. 977, 2023 | | 2023 |
| Co-stimulatory signals mediated by inducible T-cell co-stimulator (ICOS) influence the hepatic expansion auto-aggressive CD8+ T-cells in non-alcoholic steatohepatitis (NASH) C Vecchio, A Provera, L lavanya Gadipudi, RN Naik, R Boldorini, ... Journal of Hepatology 78, S751, 2023 | | 2023 |
| Cholesterol-free ketogenic diet feeding improves experimental non-alcoholic fatty liver disease (NAFLD) A Provera, RN Naik, L lavanya Gadipudi, C Vecchio, M Caputo, ... Journal of Hepatology 78, S804-S805, 2023 | | 2023 |
| Characterization of Novel Targets for Preventing Fibrosis Evolution in Nonalcoholic Fatty Liver Disease (NAFLD) A Provera Università degli Studi del Piemonte Orientale Amedeo Avogadro, 2023 | | 2023 |
| Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis (NASH) LL Gadipudi, NN Ramavath, A Provera, C Reutelingsperger, E Albano, ... | | |
